Accéder au contenu
Merck
Toutes les photos(1)

Documents

A-004-M

Sigma-Aldrich

Poly-ʟ-Ornithine

synthetic, liquid, 0.1 mg/mL, suitable for cell culture

Synonyme(s) :

Poly-L-Ornithine Solution (0.01%), A-004-M, Sigma-Aldrich

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352209
eCl@ss :
32160801
Nomenclature NACRES :
NA.75

product name

Poly-L-Ornithine Solution (0.01%),

Taille de l'aiguille

2.0 mm

Niveau de qualité

Stérilité

sterile

Forme

liquid

Poids mol.

Mw 78000 Da

Fabricant/nom de marque

NovaSeptum®

Concentration

0.01 % (w/v)
0.1 mg/mL

Technique(s)

cell attachment: suitable
cell culture | mammalian: suitable

Description générale

Research Category: Stem Cell Research

Research Sub Category: Adhesion (CAMs)

Application

Poly-L-Ornithine Solution (0.01%) has been used to coat:
  • glass-bottom plates for cell plating in a research study investigating the localization of cMET in MDA-MB-468 cells using confocal microscopy
  • culture dishes for adult human neural stem cells (ahNSCs) primary culture
  • 6-well plates for induced pluripotent stem cells (iPSCs) culture and neuronal differentiation

Qualité

Solution is clear with no particulates present. Solution is sterile and suitable for cell culture applications.

Forme physique

Product is presented in sterile water at 0.01% w/v (0.1mg/ml). Product is filtered through a 0.2 micron filter before freezing.

Notes préparatoires

1. Thaw Poly-L-Ornithine solution at room temperature.

2. Dilute Poly-L-Ornithine solution to the desired concentration in sterile water.

3. Fully coat the cell culture surface with diluted Poly-L-Ornithine solution. Use 5 mL volume for 6-cm plates and 10 mL volume for 10-cm plates and T75 flasks.

4. Allow the cell culture vessel to sit at room temperature overnight.

5. Aspirate the Poly-L-Ornithine solution the following day and rinse the vessel with sterile water followed by coating with desired ECM protein. Optimal coating concentrations must be determined by the end user. Typical coating concentrations range from 10ug/ml to 100ug/ml based on cell type and application.

Stockage et stabilité

Store at -20°C for up to 4 months from date of receipt. Avoid multiple freeze thaw cycles to maintain product integrity.

Informations légales

NOVASEPTUM is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Code de la classe de stockage

12 - Non Combustible Liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Expert opinion on biological therapy, 1137-1149 (2023)
Ryan S Hippman et al.
ACS chemical neuroscience, 14(24), 4363-4382 (2023-12-10)
Autophagy is a major catabolic degradation and recycling process that maintains homeostasis in cells and is especially important in postmitotic neurons. We implemented a high-content phenotypic assay to discover small molecules that promote autophagic flux and completed target identification and
Geun-Hyoung Ha et al.
Aging, 14(22), 8944-8969 (2022-11-30)
Mismatches between pre-clinical and clinical results of stem cell therapeutics for ischemic stroke limit their clinical applicability. To overcome these discrepancies, precise planning of pre-clinical experiments that can be translated to clinical trials and the scientific elucidation of treatment mechanisms

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique